Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
I-BFM-SG Trial for Childhood Non-B Acute Lymphoblastic Leukemia
NCT00764907Phase 3Unknown
- Sponsor
- Motol University Hospital
- Start
- Nov 2002
- Primary completion
- Oct 2007
- Modality
- Monoclonal Antibodies, Orthosteric Ligands, Replacement Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of asparaginase escherichia coli, cyclophosphamide, cytarabine, dexamethasone, pegylated liposomal doxorubicin in acute lymphoblastic leukemia (ALL), sponsored by Motol University Hospital. Status: unknown.
02
Drugs
asparaginase escherichia colicyclophosphamidecytarabinedexamethasonepegylated liposomal doxorubicin
03
Conditions
acute lymphoblastic leukemia (ALL)
Beyond the preview
Go deeper on NCT00764907.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00764907.